273 related articles for article (PubMed ID: 32832307)
1. Diabetes Mellitus and Parkinson's Disease: Shared Pathophysiological Links and Possible Therapeutic Implications.
Hassan A; Sharma Kandel R; Mishra R; Gautam J; Alaref A; Jahan N
Cureus; 2020 Aug; 12(8):e9853. PubMed ID: 32832307
[TBL] [Abstract][Full Text] [Related]
2. Association between Parkinson's Disease and Diabetes Mellitus: From Epidemiology, Pathophysiology and Prevention to Treatment.
Yu H; Sun T; He X; Wang Z; Zhao K; An J; Wen L; Li JY; Li W; Feng J
Aging Dis; 2022 Dec; 13(6):1591-1605. PubMed ID: 36465171
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of the neuroprotective effect of GLP-1 in a rat model of Parkinson's with pre-existing diabetes.
Elbassuoni EA; Ahmed RF
Neurochem Int; 2019 Dec; 131():104583. PubMed ID: 31654678
[TBL] [Abstract][Full Text] [Related]
4. Type 2 Diabetes (T2DM) and Parkinson's Disease (PD): a Mechanistic Approach.
Sabari SS; Balasubramani K; Iyer M; Sureshbabu HW; Venkatesan D; Gopalakrishnan AV; Narayanaswamy A; Senthil Kumar N; Vellingiri B
Mol Neurobiol; 2023 Aug; 60(8):4547-4573. PubMed ID: 37118323
[TBL] [Abstract][Full Text] [Related]
5. Convergent Molecular Pathways in Type 2 Diabetes Mellitus and Parkinson's Disease: Insights into Mechanisms and Pathological Consequences.
Xxxx S; Ahmad MH; Rani L; Mondal AC
Mol Neurobiol; 2022 Jul; 59(7):4466-4487. PubMed ID: 35575870
[TBL] [Abstract][Full Text] [Related]
6. Common pathophysiology affecting diabetic retinopathy and Parkinson's disease.
Tian T; Li Z; Lu H
Med Hypotheses; 2015 Oct; 85(4):397-8. PubMed ID: 26141638
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs, Parkinson's Disease, and Diabetes Mellitus.
Wang H
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799467
[TBL] [Abstract][Full Text] [Related]
8. The Association Between Type 2 Diabetes Mellitus and Parkinson's Disease.
Cheong JLY; de Pablo-Fernandez E; Foltynie T; Noyce AJ
J Parkinsons Dis; 2020; 10(3):775-789. PubMed ID: 32333549
[TBL] [Abstract][Full Text] [Related]
9. Does Parkinson's disease and type-2 diabetes mellitus present common pathophysiological mechanisms and treatments?
Lima MM; Targa AD; Noseda AC; Rodrigues LS; Delattre AM; dos Santos FV; Fortes MH; Maturana MJ; Ferraz AC
CNS Neurol Disord Drug Targets; 2014 Apr; 13(3):418-28. PubMed ID: 24059307
[TBL] [Abstract][Full Text] [Related]
10. Elucidating the Relationship Between Diabetes Mellitus and Parkinson's Disease Using
Kong Y; Zhou H; Feng H; Zhuang J; Wen T; Zhang C; Sun B; Wang J; Guan Y
Front Neurosci; 2020; 14():682. PubMed ID: 32760240
[TBL] [Abstract][Full Text] [Related]
11. Metformin role in Parkinson's disease: a double-sword effect.
Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Ashour NA; Jabir MS; Negm WA; Batiha GE
Mol Cell Biochem; 2024 Apr; 479(4):975-991. PubMed ID: 37266747
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
13. Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links.
De Rosa S; Arcidiacono B; Chiefari E; Brunetti A; Indolfi C; Foti DP
Front Endocrinol (Lausanne); 2018; 9():2. PubMed ID: 29387042
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective strategies to prevent and treat Parkinson's disease based on its pathophysiological mechanism.
Lee Y; Kim MS; Lee J
Arch Pharm Res; 2017 Oct; 40(10):1117-1128. PubMed ID: 28952032
[TBL] [Abstract][Full Text] [Related]
15. Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson's Disease.
Song J; Kim J
Front Aging Neurosci; 2016; 8():65. PubMed ID: 27065205
[TBL] [Abstract][Full Text] [Related]
16. The Relevance of Insulin Action in the Dopaminergic System.
Fiory F; Perruolo G; Cimmino I; Cabaro S; Pignalosa FC; Miele C; Beguinot F; Formisano P; Oriente F
Front Neurosci; 2019; 13():868. PubMed ID: 31474827
[TBL] [Abstract][Full Text] [Related]
17. The risk of Parkinson's disease in diabetic people: an updated systematic review and meta-analysis.
Azami M; Moradkhani A; Afraie M; Khateri S; Sharifian E; Zamani K; Moradi Y
Acta Neurol Belg; 2024 Jun; 124(3):775-790. PubMed ID: 37982931
[TBL] [Abstract][Full Text] [Related]
18. Diabetes Mellitus and Parkinson's Disease: A Systematic Review and Meta-Analyses.
Komici K; Femminella GD; Bencivenga L; Rengo G; Pagano G
J Parkinsons Dis; 2021; 11(4):1585-1596. PubMed ID: 34486987
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of type 1 diabetes mellitus as a risk factor of Parkinson's disease in a Drosophila model.
Sanz FJ; Martínez-Carrión G; Solana-Manrique C; Paricio N
J Exp Zool A Ecol Integr Physiol; 2023 Oct; 339(8):697-705. PubMed ID: 37381093
[TBL] [Abstract][Full Text] [Related]
20. Two Birds One Stone: The Neuroprotective Effect of Antidiabetic Agents on Parkinson Disease-Focus on Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors.
Lin KJ; Wang TJ; Chen SD; Lin KL; Liou CW; Lan MY; Chuang YC; Chuang JH; Wang PW; Lee JJ; Wang FS; Lin HY; Lin TK
Antioxidants (Basel); 2021 Dec; 10(12):. PubMed ID: 34943038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
